- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02688192
Mobile Health Fitness Program for Adolescent and Young Adult Childhood Cancer Survivors (TLCFIT)
Teens Living With Cancer Fitness Improvement Training (TLCFIT): A Novel Mobile Health Fitness Program for Adolescent and Young Adult (AYA) Childhood Cancer Survivors
Studieoversigt
Status
Betingelser
Detaljeret beskrivelse
PRIMARY OBJECTIVES:
I. Evaluate the feasibility of the technology-enhanced (electronic accelerometer + app + 8 weekly group sessions) fitness program in a pilot randomized clinical trial.
SECONDARY OBJECTIVES:
I. Determine the effectiveness of the technology-enhanced fitness program on participants' cardiorespiratory fitness and muscular fitness.
II. Examine the effects of the program on secondary outcomes of health related quality of life (HRQOL) and fatigue.
OUTLINE:
Participants are randomized to 1 of 2 arms.
ARM I (Intervention): Participants attend 8 group meetings weekly, wear an electronic accelerometer, engage in private social support messaging within the app and Facebook private groups, and then use the mobile app for 4 weeks without in-person groups.
ARM II (WAITLIST CONTROL [WLC]): After the 6 month assessment, participants receive the FitSurvivor intervention as in arm I.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
New Jersey
-
Hackensack, New Jersey, Forenede Stater, 07601
- Hackensack University Medical Center
-
New Brunswick, New Jersey, Forenede Stater, 08903
- Rutgers Cancer Institute of New Jersey
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Any diagnosis of cancer prior to age 21
- Off treatment for at least 6 months
- For patients < 18 years, parents must give informed consent and patient must give assent; patients >= 18 must give informed consent
Exclusion Criteria:
- Any medical contraindication to exercise according to a physician or physician's designee
- Non-English speaking
- Current physical activity level exceeding Centers for Disease Control and Prevention (CDC) guidelines for activity (60 min of moderate-vigorous exercise/day for 5+ days/week (wk) including 3+ days of vigorous intensity activities and muscle-strengthening exercises on 3+ days/wk and bone strengthening exercises on 3+ days/wk for children < 18 and 150 min of moderate vigorous exercise or 75 min of vigorous exercise/wk and 2+ days of muscle strengthening activities for adults >= 18); the CDC guidelines are used to determine exercise prescription in our intervention; individuals already exceeding the guidelines would be unlikely to benefit from participating
- Significant developmental delay per patient, parent, or physician report
- Pregnant (per patient report); if participant becomes pregnant during the course of the study, she will be removed from further participation
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Arm I (Intervention)
Assessment including
|
Hjælpestudier
Andre navne:
Participate in fitness program
Engage in private social support messaging and Use the mobile app
Wear an electronic accelerometer
Andre navne:
|
|
Aktiv komparator: Arm II (Waitlist Control [WLC])
Assessment including
After waiting 6 months they will begin the fitness program as described in Arm I |
Hjælpestudier
Andre navne:
Participate in fitness program
Engage in private social support messaging and Use the mobile app
Wear an electronic accelerometer
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Feasibility of the Technology-enhanced Fitness Program
Tidsramme: Baseline
|
Feasibility will be evaluated by the number of participants who enroll and complete baseline assessment for the randomized trial.
In total, 354 participants were mailed letters; 68 were contacted/screened, of which 56 were eligible and 49 enrolled (88% of those screened eligible, 14% of total potentially eligible pool).
|
Baseline
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Feasibility - Retention
Tidsramme: Baseline to post-intervention (3 months)
|
Percentage of participants who compete the 3 month assessment
|
Baseline to post-intervention (3 months)
|
|
Fatigue Measured Using the PedsQL Multidimensional Fatigue Scale
Tidsramme: Baseline to post-intervention (3 months)
|
Fatigue measured using the PedsQL Multidimensional Fatigue Scale.
The PedsQL Multidimensional Fatigue Scale yields three subscales: general, sleep/rest, and cognitive fatigue.
Scores are transformed on a 0-100 scale, with higher scores indicating better functioning.
|
Baseline to post-intervention (3 months)
|
|
Health Related Quality of Life (HRQL) Measured Using the Pediatric Quality of Life Inventory (PedsQL) Generic Core Scale
Tidsramme: Baseline to post-intervention (3 months)
|
The PedsQL Generic Core Scale is a well-validated measure of HRQOL with physical, emotional, social, and cognitive functioning domains.
The PedsQL Generic Core yields two summary scores - Physical Summary and Psychosocial Summary.
Scores are transformed on a 0-100 scale, with higher scores indicating better functioning.
|
Baseline to post-intervention (3 months)
|
|
Change in Cardiorespiratory Fitness Measured Using Submaximal Treadmill Test
Tidsramme: Baseline to post-intervention (3 months)
|
Cardiorespiratory fitness was measured via submaximal treadmill testing using a modified Bruce protocol.
This standardized graded treadmill test adds two warm-up stages, with the first performed at a 1.7 mph and 0% grade and the second at 1.7 mph and 5% grade.
Participants performed the graded exercise test until they reached 85% of their age-predicted maximum heart rate, which was measured using a chest-worn Polar heart rate monitor.
Estimated VO2 max was calculated for each participant using the multi-stage model and American College of Sports Medicine metabolic equations.
|
Baseline to post-intervention (3 months)
|
|
Change in Muscle Strength/Endurance Measured Using 10-repetition Maximum Strength Tests (Upper and Lower Body)
Tidsramme: Baseline to post-intervention (3 months)
|
Lower and upper body muscular strength/endurance were measured via 10-repetition maximum (10-RM) tests following National Strength and Conditioning Association guidelines (leg press machine for lower body and barbell bench press for upper body).
Weight was increased until participants executed 10 repetitions in good form for both exercises.
Estimates of 1-RM leg and bench press were made using a linear prediction equation.
Higher scores indicate greater muscular strength/endurance.
|
Baseline to post-intervention (3 months)
|
|
Feasibility - Engagement With the App
Tidsramme: Duration of the FitSurvivor intervention (12 weeks)
|
Engagement with the app was measured by 1) number of in-app exercises completed; 2) points earned (more active = more points); 3) achievements unlocked; and 4) number of likes and comments posted within the social feed.
These are count data.
Achievements unlocked has possible range of 0 to 20.
Number of in-app exercises completed, points earned, and number of likes and comments posted within the social feed have a possible lower limit of 0 and no upper limit; higher numbers indicate more instances of each.
The full range of participant data are: number of in-app exercises completed = 0-44; points earned = 0-1,195; number of achievements unlocked = 1-20; number of likes/comments posted = 0-8.
|
Duration of the FitSurvivor intervention (12 weeks)
|
Samarbejdspartnere og efterforskere
Efterforskere
- Ledende efterforsker: Katie Devine, Rutgers Cancer Institute of New Jersey
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- Pro2013003658
- P30CA072720 (U.S. NIH-bevilling/kontrakt)
- NCI-2015-01841 (Registry Identifier: CTRP (Clinical Trial Reporting Program))
- 131323 (Anden identifikator: Rutgers Cancer Institute of New Jersey)
- K07CA174728 (U.S. NIH-bevilling/kontrakt)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Livskvalitetsvurdering
-
Seoul National University HospitalTrukket tilbageDepression | Postoperative komplikationer | Angst | MestringsadfærdKorea, Republikken
-
Memorial Sloan Kettering Cancer CenterAfsluttetAscitesForenede Stater
-
Latin American Cooperative Oncology GroupRoche Pharma AG; EVA - Grupo Brasileiro de Tumores GinecológicosAfsluttet
-
Ankara UniversityAfsluttetStørre abdominal kirurgi | Patientrapporteret resultatKalkun
-
Kutahya Health Sciences UniversityAfsluttetKronisk smerte | Juvenil idiopatisk arthritisKalkun
-
University of FloridaAfsluttet
-
World Vision CanadaRyerson University; World Health Organization; Global Affairs Canada; Ministry...AfsluttetDiarré | Malaria | Akut luftvejsinfektion
-
Maastricht UniversityTNO; Netherlands Instititute for Health Services Research; University of...AfsluttetHjertefejl | Diabetes mellitus, type 2 | Kronisk obstruktiv lungesygdom | AstmaHolland
-
University Hospital, Strasbourg, FranceAfsluttetKirurgisk indgreb | MindreFrankrig
-
King's College LondonGuy's and St Thomas' NHS Foundation TrustAfsluttet